Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg Exporter in India – Healthy Inc

Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg | Exporter
Product image for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg Exporter; regulatory dossiers & international shipping.
Product Information
| Generic Name | Paracetamol and Orphenadrine Citrate |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049099 |
| Pharmacopoeia | IP / BP |
| Product Type | Tablet |
| Category | Analgesic and Muscle Relaxant Combination |
| Subcategory | Analgesic and Muscle Relaxant Combination |
| Active Ingredient | Paracetamol and Orphenadrine Citrate |
| Strength | 35 mg + 450 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Analgesic and Muscle Relaxant Combination |
Medicine Details & Safety
| Short Description | Healthy Inc invites international procurement enquiries for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. Relief of pain and functional stiffness in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. 2. Management of acute painful musculoskeletal disorders, tenosynovitis, lumbago, dentalgia, and post-traumatic injury. | ||||||||||||||||||||||||
| Full Description | Healthy Inc invites international procurement enquiries for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility. Product technical specifications
Product technical specifications
Export regulatory and dossier readinessIdentify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.Climatic zone stability and export artworkFor Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.Global logistics and trade termsSpecify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.International buyer requirementsEnquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally with a full glass of water, preferably with or immediately following meals to minimize gastric irritation. Do not exceed the maximum prescribed daily dosage. Use the lowest effective dose for the shortest treatment duration necessary. | ||||||||||||||||||||||||
| Side Effects | Common: Epigastric discomfort, dyspepsia, heartburn, nausea, abdominal pain. Uncommon: Dizziness, headache, mild diarrhea, flatulence, constipation. Rare: Peptic ulceration, gastrointestinal hemorrhage, elevated transaminases, hypersensitivity rash. | ||||||||||||||||||||||||
| Warnings and Precautions | Gastrointestinal Safety: Long-term administration can lead to gastric mucosal erosion, ulceration, or bleeding. Cardiovascular & Renal Caution: Use with caution in patients with preexisting hypertension, congestive heart failure, or renal compromise. Monitor renal parameters periodically. | ||||||||||||||||||||||||
| Contraindications | 1. Known hypersensitivity to Paracetamol and Orphenadrine Citrate, aspirin, or other NSAIDs. 2. Active peptic ulcer disease, gastrointestinal hemorrhage, or history of perforation. 3. Severe heart failure (NYHA Class III-IV), severe hepatic cirrhosis, or advanced renal failure. 4. Third trimester of pregnancy. | ||||||||||||||||||||||||
| Drug Interactions | 1. Anticoagulants & Antiplatelets (Warfarin, Clopidogrel): Increased risk of serious GI bleeding. 2. ACE Inhibitors, ARBs & Diuretics: Attenuated antihypertensive efficacy and increased nephrotoxicity risk. 3. Methotrexate & Lithium: Reduced renal clearance causing elevated serum concentrations and toxicity. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Which registration documents can be requested for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg? | Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review. |
| Is Zone IVb data available for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg? | Request confirmation for the exact formulation and packaging configuration. |
| Can export artwork be multilingual for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg? | Provide the required languages and approved regulatory artwork for review. |
| Which shipping terms can be discussed for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg? | EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement. |
| How do I obtain an export quotation for Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg? | Provide destination country, quantity, documentation requirements and preferred trade terms. |
Related Products
✚
Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg ManufacturerView product →
✚
Paracetamol and Orphenadrine Citrate Tablets 35 mg + 450 mg SupplierView product →
✚
Paracetamol and Orphenadrine Citrate Tablets BP 450 mg + 35 mg ExporterView product →
✚
Paracetamol and Orphenadrine Citrate Tablets BP 450 mg + 35 mg ManufacturerView product →
✚
Paracetamol and Orphenadrine Citrate Tablets BP 450 mg + 35 mg SupplierView product →
Latest Posts
✚
What are acarbose tablets used for?Read article →✚
amikacin injection product usageRead article →✚
bharat-s-leading-pharmaceutical-manufacturerRead article →✚
india's leading pharmaceutical manufacturerRead article →✚
WHO GMP certfied Hydralazine hydrochloride Tablets ManufacturerRead article →✚
WHO GMP certfied Haloperidol Tablets ManufacturerRead article →✚
WHO GMP certfied Griseofulvin Tablets ManufacturerRead article →✚
WHO GMP certfied Glyceryl Trinitrate Tablets ManufacturerRead article →